MA07.03 Systematic Engineering of TROP2 CAR T Cell Therapy to Overcome Resistance Pathways in EGFRmutant NSCLC
Elliott J. Brea(Dana-Farber Cancer Institute), Simon Baldacci(Dana-Farber Cancer Institute), Soumendu Chakravarti(Dana-Farber Cancer Institute), Alexis Mottram(Dana-Farber Cancer Institute), Fabio Facchinetti(Dana-Farber Cancer Institute), Aparna Ramasubramanian(Dana-Farber Cancer Institute), Nerina Savage(Dana-Farber Cancer Institute), Kenneth Ngo(Dana-Farber Cancer Institute), Ha Vo(Dana-Farber Cancer Institute), Brittaney A. Leeper(Dana-Farber Cancer Institute), Elena V. Ivanova(Dana-Farber Cancer Institute), Adrian Saldanha(Dana-Farber Cancer Institute), Marie-Anaïs Locquet(Dana-Farber Cancer Institute), Abdulmajeed Salamah(Dana-Farber Cancer Institute), Carla Stornante(Dana-Farber Cancer Institute), Marco Campisi(Dana-Farber Cancer Institute), N.R. Mahadevan(Dana-Farber Cancer Institute), Tran C. Thai(Dana-Farber Cancer Institute), T.J. Haggerty(Dana-Farber Cancer Institute), Cui Nie(Suzhou Research Institute), Chao Deng(Suzhou Research Institute), Xuguang Wang(Suzhou Research Institute), Lijia Liu(Suzhou Research Institute), Prafulla C. Gokhale(Dana-Farber Cancer Institute), Cloud P. Paweletz(Dana-Farber Cancer Institute), Pasi A. Jänne(Dana-Farber Cancer Institute), D.A. Barbie(Dana-Farber Cancer Institute), Elizabeth Smith(Dana-Farber Cancer Institute)
Cited by 2Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis